These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11084985)

  • 1. Current status of food animal antidotes.
    Post LO; Keller WC
    Vet Clin North Am Food Anim Pract; 2000 Nov; 16(3):445-53, vi. PubMed ID: 11084985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update of antidote availability in veterinary medicine.
    Post LO; Keller WC
    Vet Hum Toxicol; 1999 Aug; 41(4):258-61. PubMed ID: 10434385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidotes in food animal practice.
    Haskell SR; Payne M; Webb A; Riviere J; Craigmill AL
    J Am Vet Med Assoc; 2005 Mar; 226(6):884-7. PubMed ID: 15786990
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of the food animal veterinarian in the HACCP era.
    Buntain B
    J Am Vet Med Assoc; 1997 Feb; 210(4):492-5. PubMed ID: 9040834
    [No Abstract]   [Full Text] [Related]  

  • 5. The issue of extralabel drug use.
    Kennedy JA
    J Am Vet Med Assoc; 1997 Dec; 211(11):1354. PubMed ID: 9394877
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of animal toxicoses: a regulatory perspective.
    Bright SJ; Murphy MJ; Steinschneider JC; Lovell RA; Post LO
    Vet Clin North Am Food Anim Pract; 2011 Jul; 27(2):481-512, x. PubMed ID: 21575782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The US Food and Drug Administration Modernization Act of 1997: impact on consumers.
    Golodner LF
    Clin Ther; 1998; 20 Suppl C():C20-5. PubMed ID: 9915086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
    Roller ST; Pippins RR; Ngai JW
    Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Professional responsibilities.
    Jenkins WL
    J Am Vet Med Assoc; 1993 May; 202(10):1742-3. PubMed ID: 8514601
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA prohibits extralabel use of two drug classes.
    J Am Vet Med Assoc; 1997 Aug; 211(3):269. PubMed ID: 9262656
    [No Abstract]   [Full Text] [Related]  

  • 11. Legal considerations--testing the "residue of toxicological concern".
    Landa MM
    Drug Metab Rev; 1995; 27(4):581-90. PubMed ID: 8925719
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the advisory services provided by the Food Animal Residue Avoidance Databank.
    Wang J; Gehring R; Baynes RE; Webb AI; Whitford C; Payne MA; Fitzgerald K; Craigmill AL; Riviere JE
    J Am Vet Med Assoc; 2003 Dec; 223(11):1596-8. PubMed ID: 14664445
    [No Abstract]   [Full Text] [Related]  

  • 13. Congress strengthens pet food safety regulations.
    Nolen RS
    J Am Vet Med Assoc; 2007 Nov; 231(9):1320-1. PubMed ID: 17975986
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparative analysis of drug safety withdrawals in the UK and the US (1971-1992): implications for current regulatory thinking and policy.
    Abraham J; Davis C
    Soc Sci Med; 2005 Sep; 61(5):881-92. PubMed ID: 15955393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Greater and lesser powers of tort reform: the primary jurisdiction doctrine and state-law claims concerning FDA-approved products.
    Struve CT
    Cornell Law Rev; 2008 Jul; 93(5):1039-74. PubMed ID: 18618970
    [No Abstract]   [Full Text] [Related]  

  • 16. The FDA defense: a prescription for easing the pain of punitive damage awards in medical products liability cases.
    Marthaler AL
    Spec Law Dig Health Care Law; 1997 Sep; (223):9-45. PubMed ID: 10173273
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of US pathway for approving medical devices for rare conditions.
    Hwang TJ; Carpenter D; Kesselheim AS
    BMJ; 2014 Jan; 348():g217. PubMed ID: 24443478
    [No Abstract]   [Full Text] [Related]  

  • 18. The human food safety evaluation of new animal drugs.
    Friedlander LG; Brynes SD; Fernández AH
    Vet Clin North Am Food Anim Pract; 1999 Mar; 15(1):1-11, vii. PubMed ID: 10088208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug review "behind the curtain": a response to Professor Struve.
    O'Reilly JT
    Cornell Law Rev; 2008 Jul; 93(5):1075-90. PubMed ID: 18618971
    [No Abstract]   [Full Text] [Related]  

  • 20. An overview of new guidelines on the use and dispensing of veterinary drugs.
    Sterner KE
    J Am Vet Med Assoc; 1991 Mar; 198(5):825-6. PubMed ID: 2026529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.